Skip to content

RHYTHM PHARMACEUTICALS, INC.

RYTM

CIK 0001649904

← back to feed
Revenue (TTM)
$192.62M
+45.8% YoY Q1 May 2026
Net Income (TTM)
−$204.67M
+24.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.21
+28.3% YoY Q1 May 2026
Gross Margin
88.7%
Q1 May 2026
Operating Margin
-102.4%
Q1 May 2026
Net Margin
-106.3%
Q1 May 2026
Free Cash Flow (TTM)
−$162.71M
Q1 May 2026
Cash
$62.14M
Q1 May 2026
Total Debt
$108.47M
Q1 May 2026
Shares Outstanding
68.53M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings